EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Hippo Pathway in Cutaneous Melanoma

Urszula Kazimierczak, Anna Przybyla, Marianna Smielowska, Tomasz Kolenda, Andrzej Mackiewicz iD

Cells · 2024

DOI: 10.3390/cells13121062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Urszula Kazimierczak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology, Poznan University of Medical Sciences, Rokietnicka Street 8, 61-806 Poznan, Poland. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Hippo Signaling Pathway, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is the most aggressive form of skin cancer. In the advanced stage of development, it is resistant to currently available therapeutic modalities. Increased invasiveness and metastatic potential depend on several proteins involved in various signal transduction pathways. Hippo signaling plays a vital role in malignant transformation. Dysfunctions of the Hippo pathway initiate the expression of tumor growth factors and are associated with tumor growth and metastasis formation. This review summarizes the recent achievements in studying the role of the Hippo pathway in melanoma pathogenesis and points to the potential specific targets for anti-melanoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHippo Signaling PathwaySignal TransductionProtein Serine-Threonine KinasesHumansAnimalsCutaneous Malignant MelanomaMolecular Targeted Therapy

Stichwörter der Autor:innen

Hippo pathwaycutaneous melanomatherapeutic targets

Substanzen

Protein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Cancer Immunology, Poznan University of Medical Sciences, Rokietnicka Street 8, 61-806 Poznan, Poland.
  • Department of Genome Engineering, The Institute of Bioorganic Chemistry, Polish Academy of Sciences, Z. Noskowskiego 12/14, 61-704 Poznan, Poland.
  • Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
  • Research and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
  • Department of Cancer Diagnostics and Immunology, Greater Poland Cancer Centre, Garbary Street 15, 61-866 Poznan, Poland.

ORCID-Profile: Andrzej Mackiewicz

Förderung

  • National Science Centre Poland

Zitieren

APA

Kazimierczak, U., Przybyla, A., Smielowska, M., Kolenda, T., & Mackiewicz, A. (2024). Targeting the Hippo Pathway in Cutaneous Melanoma. Cells. https://doi.org/10.3390/cells13121062

Vancouver

Kazimierczak U, Przybyla A, Smielowska M, Kolenda T, Mackiewicz A. Targeting the Hippo Pathway in Cutaneous Melanoma. Cells. 2024. doi:10.3390/cells13121062

BibTeX
@article{Kazimierczak2024,
  author = {Kazimierczak, Urszula and Przybyla, Anna and Smielowska, Marianna and Kolenda, Tomasz and Mackiewicz, Andrzej},
  title = {Targeting the Hippo Pathway in Cutaneous Melanoma},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13121062}
}
Kostenlos starten →